Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients
Journal of Clinical Imaging Science · 13.08.2026 · 16 · 31
DOI: 10.25259/jcis_238_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Imaging Science, online erschienen am 13.08.2026. Verfasst von Ethan Oren Cohen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Imaging, Division of Diagnostic Imaging, Houston, Texas, United States. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Objectives
To evaluate the effect of COVID-19 on a mobile screening mammography program as measured by turnaround time (TAT) in days between an abnormal screening mammogram (sMG) and diagnostic mammography. Material and Methods: All of our institution’s sMG (mobile and non-mobile) from January 2017, to December 2022 were retrospectively reviewed, and those dated March 7, 2020–July 7, 2020 were excluded because our mobile sMG program was non-operative at that time due to COVID-19. TATs and patient demographics were compared for mobile and non-mobile sMG patients between 2 time periods: Pre-pandemic (January 1, 2017–March 6, 2020) and pandemic (July 8, 2020–December 31, 2022). Statistics included multiple linear regression analysis, Fisher’s Exact, and Wilcoxon Rank Sum tests.
Results
During the pre-pandemic period, 11,439 female patients (9309 without insurance, 81.3%) underwent 14,161 mobile sMG, while 28,737 female patients (429 without insurance, 1.5%) underwent 57,840 non-mobile sMG. During the pandemic period, 6805 female patients (6720 without insurance, 98.8%) underwent 7663 mobile sMG, while 32,655 female patients (868 without insurance, 2.7%) underwent 53,540 non-mobile sMG. Median TATs for mobile uninsured patients increased from 41 days during the pre-pandemic period to 51 days during the pandemic period ( p < 0.001), while median TATs for non-mobile insured patients decreased from 20 days during the pre-pandemic period to 14 days during the pandemic period ( p < 0.001). Increased TATs were associated with Asian, African American, and Other race compared with White race (Asian, p = 0.004; African American, p < 0.001; and Other, p = 0.02) and self-pay insurance status ( p = 0.006).
Conclusion
For mobile uninsured screening patients, the number of days between screening and diagnostic mammography increased with the COVID-19 pandemic, while it decreased for non-mobile insured screening patients. Mobile uninsured mammography patients may represent a population that needs additional attention. These findings highlight a health equity concern, as the pandemic disproportionately widened disparities in timely follow-up care for uninsured patients served by mobile mammography programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Imaging, Division of Diagnostic Imaging, Houston, Texas, United States.
- Department of Nuclear Medicine, Division of Diagnostic Imaging, Houston, Texas, United States.
- Division of Information Services, Department of Enterprise Data Engineering, and Analytics, Houston, Texas, United States.
- Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
ORCID-Profile: Ethan Oren Cohen
Förderung
- NCI NIH HHS
Zitieren
APA
Cohen, E. O., DeSai, C., Young, C., Sun, J., & Whitman, G. J. (2026). Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients. Journal of Clinical Imaging Science, 16, 31. https://doi.org/10.25259/jcis_238_2025
Vancouver
Cohen EO, DeSai C, Young C, Sun J, Whitman GJ. Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients. Journal of Clinical Imaging Science. 2026;16:31. doi:10.25259/jcis_238_2025
BibTeX
@article{Cohen2026,
author = {Cohen, Ethan Oren and DeSai, Charisma and Young, Chingyi and Sun, Jia and Whitman, Gary J},
title = {Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients},
journal = {Journal of Clinical Imaging Science},
year = {2026},
volume = {16},
pages = {31},
doi = {10.25259/jcis_238_2025}
}
EUVIMED